Search the Site


test tubes

To Those Who Have Yet to Subscribe:

publication date: Nov 9, 2010

A Reminder from

This email is to serve as a reminder that all $50 off promo codes 'members50', 'tweet50', and 'twt50' will be expiring on November 15th. After that date the cost of an annual subscription will be $295. 
Less than one month ago we launched our paid subscription service, combining and The positive feedback we have recieved for the new site has been incredible.  We have over 500 paid subscribers and 300 active forum users. BioRunUp is an excellent trading community- one that is constantly analyzing the biotech sector and discovering new methods to profit from FDA and Clinical catalysts.
A recent example of the value of our service is our coverage of ASTM.  We highlighted ASTM and its upcoming clinical trial results on October 18th, when it was trading at $1.52 a share.  Since that time ASTM has surged to a high of $3.89, a gain of over 155%.
Take a look at the trading history of the co-authors of according to
Mike Havrilla - ranked in the top 1% of dollar gains  (#10 out of 1550)
$179K in verified profits
64% Winning Percentage
Mark Messier - ranked in the top 1% in percentage gains (#13 out of 1550)
$33K in verified profits
32.9% Average Gain is ranked 5th out of all newsletter services, and is #1 in the biotech sector. is much more than a paid FDA calendar. Benefits of membership to BioRunUp include:
- Detailed Reports on Upcoming FDA / Clinical Trades
- Analyst Reports with consistently updated summaries 
- Run-Up Valuation Studies
- Weekly Newsletter
- Email / SMS (Text Message) Alerts of critical news
- A New Clinical Calendar
- Screenshots of BioRunUp and mikehavRx's Trading Accounts
- BioRunUp Forums - A community of informed traders
- A More Detailed FDA Calendar, linked to PDF reports
- Historical FDA Tracker 
- BioRunUp Live Newsfeed
- Spreadsheet download for clinical / regulatory catalyst calendar
- Corporate Event Google Calendar tracking for bio-catalyst stocks
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- HavRx Healthcare Sub-Sector Indexes
- Increased Organization of Tracking Upcoming Catalysts
- A Growing Focus on Upcoming Clinical Trial Catalysts
- Direct Email Communication
- Affiliate Program, earn $50 for every referral who joins
Remember to use the promocode 'members50' before November 15th to save $50
We hope that you can join us in this endeavor.
Mark Messier
BioRunUp, LLC
Mike Havrilla
mikehavRx, LLC